X4 Pharmaceuticals (XFOR) Selling, General & Administrative (2017 - 2026)
X4 Pharmaceuticals' Selling, General & Administrative came in at $8.5 million for Q2 2026, down 10.8% from $9.53 million a year earlier but up 22.0% from the prior quarter.
Powered by 
Analysis
X4 Pharmaceuticals (XFOR) Selling, General & Administrative (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, X4 Pharmaceuticals reported Selling, General & Administrative of $34.44 million, down 37.8% year-over-year; for FY2025, it was $43.52 million, down 29.3% from FY2024.
- Selling, General & Administrative carries a five-year compound annual growth rate of 15.8% (FY2020 to FY2025).
- Going back by year, Selling, General & Administrative was $61.52 million in FY2024 (+73.3%), $35.51 million in FY2023 (+31.4%), $27.02 million in FY2022 (+9.4%) and $24.7 million in FY2021 (+18.0%).
- The five-year range for quarterly Selling, General & Administrative is $5.93 million (Q3 2021) to $17.44 million (Q1 2024).
- Year-over-year, Selling, General & Administrative has declined for six consecutive quarters, with an average decline of 4.8% over the last eight quarters.
- The fastest year-over-year change in Selling, General & Administrative over five years came in Q1 2024 (growth of 140.8%), and the weakest in Q1 2026 (a decline of 53.6%).
- Business Quant data shows XFOR's Selling, General & Administrative at $6.97 million (Q1 2026), $7.38 million (Q4 2025) and $11.59 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | X4 Pharmaceuticals | 357.55 Mn | -341.13 Mn | 7.19 Mn | 8.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.50 Mn |
| Mar 31, 2026 | 6.97 Mn |
| Dec 31, 2025 | 7.38 Mn |
| Sep 30, 2025 | 11.59 Mn |
| Jun 30, 2025 | 9.53 Mn |
| Mar 31, 2025 | 15.02 Mn |
| Dec 31, 2024 | 15.15 Mn |
| Sep 30, 2024 | 15.66 Mn |
| Jun 30, 2024 | 13.28 Mn |
| Mar 31, 2024 | 17.44 Mn |
| Dec 31, 2023 | 9.93 Mn |
| Sep 30, 2023 | 8.13 Mn |
| Jun 30, 2023 | 10.20 Mn |
| Mar 31, 2023 | 7.24 Mn |
| Dec 31, 2022 | 6.56 Mn |
| Sep 30, 2022 | 6.04 Mn |
| Jun 30, 2022 | 6.75 Mn |
| Mar 31, 2022 | 7.66 Mn |
| Dec 31, 2021 | 7.14 Mn |
| Sep 30, 2021 | 5.93 Mn |
API Access
X4 Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=XFOR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "XFOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=XFOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();